Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

NCT03107611 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

654

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Pimecrolimus Cream, 1%
DRUG: Placebo Cream
DRUG: Pimecrolimus Cream, 1%

Sponsor

Mylan Inc.

Collaborators

[object Object]